We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

116 hedge funds and large institutions have $39.7M invested in Cardiff Oncology in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

908% more call options, than puts

Call options by funds: $1.19M | Put options by funds: $118K

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

5% more funds holding

Funds holding: 110 → 116 (+6)

4.49% less ownership

Funds ownership: 40.45% → 35.96% (-4.5%)

19% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 37

48% less capital invested

Capital invested by funds: $76.6M → $39.7M (-$36.8M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
30
Reduced
37
Closed
13
Calls
$1.19M
Puts
$118K
Net Calls
+$1.07M
Net Calls Change
-$724K

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$643K
2
Renaissance Technologies
Renaissance Technologies
New York
+$208K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$157K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$145K
5
AQR Capital Management
AQR Capital Management
Connecticut
+$136K

Top Sellers

1
William Blair & Company
William Blair & Company
Illinois
-$2.11M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.06M
3
CS
Candriam SCA
Luxembourg
-$968K
4
Goldman Sachs
Goldman Sachs
New York
-$512K
5
ACA
Acorn Capital Advisors
New York
-$411K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$41.4K +$1.53K +747 +3%
VGA
52
Vanguard Global Advisers
Pennsylvania
$40.9K +$51.9K +25,271 New
Group One Trading
53
Group One Trading
Illinois
$40.8K -$34.3K -16,699 -40%
GSEP
54
Golden State Equity Partners
California
$39.7K – – –
PRTG
55
Post Resch Tallon Group
New York
$38.5K +$25 +12 +0.1%
Millennium Management
56
Millennium Management
New York
$37.3K -$352K -171,391 -88%
Raymond James Financial
57
Raymond James Financial
Florida
$36.7K -$8.21K -4,000 -15%
UBV
58
United Bank (Virginia)
Virginia
$36.3K – – –
CIAM
59
Caitong International Asset Management
Hong Kong
$36.1K +$45.2K +22,025 +8,157%
Invesco
60
Invesco
Georgia
$33.9K -$2.63K -1,278 -6%
PFSRSONJ
61
Police & Firemen's Retirement System of New Jersey
New Jersey
$32.5K +$24.8K +12,064 +151%
BEAM
62
Baker Ellis Asset Management
Washington
$32.4K – – –
PWS
63
Proactive Wealth Strategies
Georgia
$32.4K +$20.5K +10,000 +100%
TS
64
Tamar Securities
California
$31.3K +$16.1K +7,845 +68%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$30.2K -$1.67K -812 -4%
IIM
66
INTECH Investment Management
Florida
$26.8K -$23.5K -11,445 -41%
Simplex Trading
67
Simplex Trading
Illinois
$26.7K +$33.8K +16,454 New
FWS
68
FinDec Wealth Services
California
$25.9K – – –
Lido Advisors
69
Lido Advisors
California
$24.3K +$39 +19 +0.1%
CAWM
70
Capital Advisors Wealth Management
Washington
$24.3K +$9.24K +4,500 +43%
Mariner
71
Mariner
Kansas
$23.4K +$29.7K +14,451 New
VF
72
Virtu Financial
New York
$22K -$51.1K -24,875 -65%
TSS
73
Two Sigma Securities
New York
$21.2K +$26.9K +13,102 New
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$21.2K +$895 +436 +3%
GIA
75
Gladstone Institutional Advisory
Florida
$21.1K – – –
1 2
3
4 5

CRDF Hedge Fund Activity: Q1 2026 in Review

116 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2026, worth a combined $39.7M — down 48% from $76.6M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CRDF positions and 13 closed out — a net gain of 9 holders — while 30 added to existing stakes and 37 trimmed.

The largest buyer was UBS Group, adding an estimated $643K. The largest seller was William Blair & Company, cutting an estimated $2.11M.

  • 116 institutional investors held Cardiff Oncology (CRDF) as of Q1 2026, up from 110 in Q4 2025.
  • Funds reported $39.7M of Cardiff Oncology stock for Q1 2026, down 48% quarter-over-quarter.
  • 22 funds opened new Cardiff Oncology positions in Q1 2026 and 13 closed out, a net change of +9 holders.
  • The largest Cardiff Oncology buyer in Q1 2026 was UBS Group, an estimated $643K added.
  • The largest Cardiff Oncology seller in Q1 2026 was William Blair & Company, an estimated $2.11M sold.

Based on aggregated 13F filings for Q1 2026.